Bronchiectasis AdultHealthy Controls Group - Age and Sex-matched
Investigational drug(s) / intervention(s)
No intervention; Observational study
No intervention; Observational study: No intervention
Study summary
Individuals with bronchiectasis exhibit productive cough and recurrent lung infections as well as reduced exercise capacity, physical activity level, and respiratory and peripheral muscle strength. 6-minute walk test (6MWT) is often used to assess exercise capacity in chronic lung diseases. 6MWT is recommended to be performed along a flat corridor, at least 30 m long, with low pedestrian traffic, on a hard surface. To overcome technical limitations during 6MWT, 6-minute stepper test (6MST) has been proposed to assess exercise capacity. Another test that provides information about exercise capacity is the 1-minute sit-to-stand test (1STS). To our knowledge, there is limited information about different exercise tests including 6MST and 1STS and cardiopulmonary responses to these tests in individuals with bronchiectasis. Therefore, this study aims to compare the responses to the 6MST between individuals with bronchiectasis and healthy controls and to investigate the relationships among 6MST, 6MWT, and 1STS responses and muscle strength.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Bronchiectasis group - Inclusion criteria for the study:
* Being 18 years of age and older,
* Having a clinically stable bronchiectasis,
* To cooperate with the tests to be performed,
* Not having a cardiovascular disease, orthopedic or neurological problem that may affect the tests,
* Being willing to participate in the study.
Bronchiectasis group - Exclusion criteria:
* Being in an acute exacerbation period,
* Having a cardiovascular, orthopedic or neurological problem that may affect the tests,
* Not being willing to participate in the study.
Control group - Inclusion criteria for the study:
* Being 18 years of age and older,
* To cooperate with the tests to be performed,
* Not having a cardiovascular, orthopedic or neurological problem that may affect the tests,
* Being willing to participate in the study.
Control group - Exclusion criteria:
\- Individuals with any known internal disease and those who do not volunteer to participate in the study will not be included in the study.
Primary outcome measure(s)
Maximal inspiratory pressure — 1st day Maximal inspiratory pressure (MIP) and will be measured using aa mouth-piece pressure measurement device. The measurement will be repeated three times so that there will be no difference of 10 cmH₂O or 10%, and the highest value will be used for analysis.
Maximal expiratory pressure — 1st day Maximal expiratory pressure (MEP) and will be measured using a mouth-piece pressure measurement device. The measurement will be repeated three times so that there will be no difference of 10 cmH₂O or 10%, and the highest value will be used for analysis.
Peripheral muscle strength — 1st day Peripheral muscle strength will be assessed using a portable dynamometer. The peripheral muscle strength test will be repeated three times for the right and left sides.
6-minute stepper test responses — 1st day 6-minute stepper test will be performed, and the number of repetitions will be recorded. Cardiopulmonary responses before and after 6-minute stepper test will be recorded. 6-minute stepper test will be performed twice with 30 minutes apart.
1 minute sit-to-stand test responses — 1 minute sit-to-stand test will be performed and the repetitions will be recoded. Cardiopulmonary responses will be recorded before and after the test. 1 minute sit-to-stand test will be performed and the repetitions will be recoded. Cardiopulmonary responses will be recorded before and after the test.
6-minute walk test responses — 1st day 6-minute walk test will be performed, and the distance walked will be recorded. Cardiopulmonary responses before and after 6-minute walk test will be recorded.
Trial sites (1)
Facility
City
Region
Status
Hacettepe University Faculty of Physical Therapy and Rehabilitation
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.